Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
or

Regeneron Pharmaceuticals (REGN)

Regeneron Pharmaceuticals (REGN)
561.49 -1.67 (-0.30%) 04/21/25 [NASDAQ]
N/A x N/A N/A x N/A
Realtime by (Cboe BZX)
N/A x N/A N/A x N/A
Realtime 561.49 unch (unch) 17:54 ET
Quote Overview for Mon, Apr 21st, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
552.97
Day High
570.35
Open 556.04
Previous Close 563.16 563.16
Volume 745,700 745,700
Avg Vol 1,089,510 1,089,510
Stochastic %K 31.77% 31.77%
Weighted Alpha -44.20 -44.20
5-Day Change +7.31 (+1.32%) +7.31 (+1.32%)
52-Week Range 525.99 - 1,211.20 525.99 - 1,211.20
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 61,567,460
  • Shares Outstanding, K 109,325
  • Annual Sales, $ 14,202 M
  • Annual Income, $ 4,413 M
  • EBIT $ 3,991 M
  • EBITDA $ 4,474 M
  • 60-Month Beta 0.44
  • Price/Sales 4.23
  • Price/Cash Flow 12.02
  • Price/Book 2.05

Options Overview Details

View History
  • Implied Volatility 49.02% ( +3.90%)
  • Historical Volatility 41.23%
  • IV Percentile 97%
  • IV Rank 74.19%
  • IV High 60.01% on 04/08/25
  • IV Low 17.43% on 06/12/24
  • Put/Call Vol Ratio 0.47
  • Today's Volume 1,537
  • Volume Avg (30-Day) 1,852
  • Put/Call OI Ratio 1.07
  • Today's Open Interest 40,230
  • Open Int (30-Day) 39,887

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 25 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate 7.00
  • Number of Estimates 6
  • High Estimate 7.78
  • Low Estimate 5.73
  • Prior Year 7.97
  • Growth Rate Est. (year over year) -12.17%

Price Performance

See More
Period Period Low Period High Performance
1-Month
525.99 +6.75%
on 04/09/25
Period Open: 658.48
667.46 -15.88%
on 03/24/25
-96.99 (-14.73%)
since 03/21/25
3-Month
525.99 +6.75%
on 04/09/25
Period Open: 687.80
748.29 -24.96%
on 03/10/25
-126.31 (-18.36%)
since 01/21/25
52-Week
525.99 +6.75%
on 04/09/25
Period Open: 896.82
1,211.20 -53.64%
on 08/27/24
-335.33 (-37.39%)
since 04/19/24

Most Recent Stories

More News
Regeneron Announces Investor Conference Presentations

REGN : 561.49 (-0.30%)
Regeneron Provides Update on EYLEA HD® (aflibercept) Injection 8 mg Supplemental Biologics License Application

REGN : 561.49 (-0.30%)
Dupixent® (dupilumab) Approved in the U.S. as the First New Targeted Therapy in Over a Decade for Chronic Spontaneous Urticaria (CSU)

REGN : 561.49 (-0.30%)
SNY : 50.93 (+0.06%)
EYLEA HD® (aflibercept) Injection 8 mg sBLA Accepted for FDA Priority Review for Both the Treatment of Macular Edema Following Retinal Vein Occlusion (RVO) and for Monthly Dosing in Approved Indications

REGN : 561.49 (-0.30%)
What to Expect From Regeneron's Next Quarterly Earnings Report

Regeneron is gearing up to report its first-quarter results later this month, with market expectations pointing to a double-digit decline in earnings.

XLV : 132.57 (-2.16%)
$SPX : 5,158.20 (-2.36%)
REGN : 561.49 (-0.30%)
Immuno-Oncology Stocks Q4 In Review: Exact Sciences (NASDAQ:EXAS) Vs Peers

Immuno-Oncology Stocks Q4 In Review: Exact Sciences (NASDAQ:EXAS) Vs Peers

NTRA : 142.23 (-3.95%)
EXAS : 43.10 (+3.66%)
INCY : 56.80 (-2.42%)
REGN : 561.49 (-0.30%)
Reflecting On Immuno-Oncology Stocks’ Q4 Earnings: Regeneron (NASDAQ:REGN)

Reflecting On Immuno-Oncology Stocks’ Q4 Earnings: Regeneron (NASDAQ:REGN)

NTRA : 142.23 (-3.95%)
EXAS : 43.10 (+3.66%)
INCY : 56.80 (-2.42%)
REGN : 561.49 (-0.30%)
Stocks Spike as Trump Announces 90-Day Tariff Pause

The S&P 500 Index ($SPX ) (SPY ) today is up +5.99%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +3.96%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +7.05%. June E-mini S&P futures (ESM25...

ALK : 43.68 (-3.32%)
GOOGL : 147.67 (-2.31%)
MPC : 126.72 (-0.78%)
AAPL : 193.16 (-1.94%)
JNJ : 156.92 (-0.35%)
AMGN : 273.68 (-1.30%)
PFE : 22.04 (-0.45%)
OXY : 39.02 (-1.74%)
TSLA : 227.50 (-5.75%)
FANG : 132.35 (-3.84%)
AMD : 85.56 (-2.22%)
SPY : 513.88 (-2.38%)
Stocks Supported by Strength in Megacap Technology and Airline Stocks

The S&P 500 Index ($SPX ) (SPY ) today is up +0.64%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.29%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +1.49%. June E-mini S&P futures (ESM25...

ALK : 43.68 (-3.32%)
GOOGL : 147.67 (-2.31%)
MPC : 126.72 (-0.78%)
AAPL : 193.16 (-1.94%)
ADI : 174.99 (-0.73%)
JNJ : 156.92 (-0.35%)
AMGN : 273.68 (-1.30%)
PFE : 22.04 (-0.45%)
OXY : 39.02 (-1.74%)
TSLA : 227.50 (-5.75%)
FANG : 132.35 (-3.84%)
AMD : 85.56 (-2.22%)
4 Beaten-Down Stocks That Could Skyrocket by 50% to 543%, According to Wall Street

As biotech investors know, companies in the industry can sometimes earn significant returns in relatively short periods, like a year, thanks to excellent clinical or regulatory progress. And based on Wall...

CRSP : 37.82 (+0.13%)
IOVA : 3.08 (+0.65%)
SRPT : 55.23 (+2.68%)
REGN : 561.49 (-0.30%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Regeneron is a biotechnology company focused on the discovery, development and commercialization of treatments targeting serious medical conditions. The company's portfolio boasts nine marketed drugs - Eylea, Dupixent, Praluent, Kevzara, Libtayo, Evkeeza, Inmazeb Arcalyst and Zaltrap. The company also...

See More

Key Turning Points

3rd Resistance Point 587.62
2nd Resistance Point 578.99
1st Resistance Point 570.24
Last Price 561.49
1st Support Level 552.85
2nd Support Level 544.22
3rd Support Level 535.47

See More

52-Week High 1,211.20
Fibonacci 61.8% 949.45
Fibonacci 50% 868.59
Fibonacci 38.2% 787.74
Last Price 561.49
52-Week Low 525.99

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Unlock High-Probability Trade Setups: Master Fractals & Time Frames Like a Pro